[1]郝圣阳,杨娅妮,马鹏程,等.龙牡安神方治疗冠心病PCI术后心胆气虚型焦虑抑郁研究进展[J].陕西中医,2026,(8):1143-1148.[doi:DOI:10.3969/j.issn.1000-7369.2026.08.024]
 HAO Shengyang,YANG Yani,MA Pengcheng,et al.Research progress on Longmu Anshen formula for treating anxiety and depression of heart and gallbladder Qi deficiency type after PCI in coronary heart disease[J].,2026,(8):1143-1148.[doi:DOI:10.3969/j.issn.1000-7369.2026.08.024]
点击复制

龙牡安神方治疗冠心病PCI术后心胆气虚型焦虑抑郁研究进展

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2026年8期
页码:
1143-1148
栏目:
综述
出版日期:
2026-08-05

文章信息/Info

Title:
Research progress on Longmu Anshen formula for treating anxiety and depression of heart and gallbladder Qi deficiency type after PCI in coronary heart disease
作者:
郝圣阳1杨娅妮1马鹏程2彭晓明2
(1.甘肃中医药大学中西医结合学院,甘肃 兰州 730030;2.甘肃中医药大学附属医院脑病科,甘肃 兰州 730030)
Author(s):
HAO Shengyang1YANG Yani1MA Pengcheng2PENG Xiaoming2
(1.Integrated Traditional Chinese and Western Medicine College,Gansu University of Chinese Medicine,Lanzhou 730030,China;2.Department of Encephalopathy,Affiliated Hospital of Gansu University of Chinese Medicine,Lanzhou 730030,China)
关键词:
龙牡安神方PCI术后心胆气虚焦虑抑郁心胆同治
Keywords:
Longmu Anshen formulaPost-PCIHeart and gallbladder Qi deficiencyAnxiety and depressionIntegrated treatment of heart and gallbladder
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7369.2026.08.024
文献标志码:
A
摘要:
经皮冠状动脉介入治疗(PCI)是冠心病血运重建的重要手段,但术后焦虑抑郁高,是不可忽视的临床问题。2014年《经皮冠状动脉介入治疗手术前后抑郁和(或)焦虑中医诊疗专家共识》将PCI术后焦虑抑郁归为中医“郁证”范畴,其中“心胆气虚证”是核心证型之一。龙牡安神方以龙骨、牡蛎为君药,配伍酸枣仁等安神定志之品,深合“心胆同治、形神共调”之旨。基于“心胆相通”理论,梳理PCI术后心胆气虚证的病机演变与证候特征,解析龙牡安神方的组方原理与药对配伍内涵,结合实验研究与临床证据,探讨其通过调节神经炎症、平衡脑内神经递质、调控应激反应轴及脑肠轴等多途径,发挥抗焦虑抑郁效应的中医机制与现代诠释,为该方的临床推广与深入研究提供理论依据。
Abstract:
Percutaneous coronary intervention (PCI) was crucial revascularization approach for coronary artery disease,high incidence of postoperative anxiety and depression has become an undeniable clinical concern.The 2014 expert consensus on traditional Chinese medicine diagnosis and treatment of depression and/or anxiety before and after PCI explicitly classified post-PCI anxiety and depression as belonging to the TCM syndrome category of Yuzheng(depression syndrome),with Heart-Gallbladder Qi deficiency syndrome being one of its core patterns.Longmu Anshen formula primarily composed of Dragon’s bone and oyster as key ingredients,combined with calming agents such as Ziziphus Jujuba seed,closely aligns with principle of treating both heart and gallbladder while harmonizing body and mind.Based on classical theory of interconnection between heart and gallbladder.This study systematically reviews pathogenic evolution and clinical characteristics of Heart-Gallbladder Qi deficiency dyndrome following PCI,analyzes formulation principles and herbal pairings of Longmu Anshen formula,and integrates experimental research and clinical evidence to explore its mechanisms in alleviating anxiety and depression through multiple pathways-such as modulating neuroinflammation,balancing neurotransmitters in the brain,and regulating the stress response axis and gut-brain axis—from both traditional Chinese medicine and modern perspectives.To provide theoretical support for clinical application and further research of this formula.

参考文献/References:

[1]冯明月.男性冠心病病人PCI术后心理状态及其影响因素分析[J].蚌埠医学院学报,2022,47(1):78-80,85.
[2]VANDIJK M R,UTENS E M,DULFER K,et al.Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up[J].Prev Cardiol,2016,23(5):552-558.
[3]HARE D L,TOUKHSATI S R,JOHANSSON P,et al.Depression and cardiovascular disease:A clinical review[J].Eur Heart J,2014,35(21):1365-1372.
[4]VACCARINO V,BREMNER J D.Stress and cardiovascular disease:An update[J].Nat Rev Cardiol,2024,21(9):603-616.
[5]王显,秦竹,赵志付.经皮冠状动脉介入治疗(PCI)手术前后抑郁和(或)焦虑中医诊疗专家共识[J].中医杂志,2015,56(4):357-360.
[6]彭晓明,丁晓华,张震文,等.龙牡安神方通过调节内侧前额叶皮质小胶质细胞极化改善CRS小鼠的焦虑行为[J].中国免疫学杂志,2024,40(11):2316-2321,2329.
[7]王伟龙,党心雨,刘立,等.基于脑肠轴理论探讨龙牡安神方对慢性束缚应激焦虑模型小鼠的影响[J].中医临床研究,2022,14(32):39-43.
[8]杨川洲,彭艳文,董宇.詹文涛教授治疗胆心综合征临床经验[J].陕西中医,2021,42(9):1276-1278.
[9]柴露露,孙明月,高蕊.冠心病经PCI术后合并焦虑抑郁的中西医诊断与治疗研究进展[J].中西医结合心脑血管病杂志,2019,17(3):375-378.
[10]邹景宇.消化性溃疡中医证型分布与焦虑、抑郁的相关性研究[J].陕西中医,2016,37(5):580-582.
[11]李深广,杜晓妹,唐文超.中医整体观下的失眠诊疗[M].上海:上海交通大学出版社:238.
[12]郑丰杰.《伤寒论》辨治心阳虚三方证治解析[J].北京中医药大学学报,2016,39(12):973-977.
[13]赵洋,刘安澜,白慧俊,等.柴胡加龙骨牡蛎汤治疗热郁少阳型抑郁症患者的临床疗效观察[J].世界中医药,2025,20(20):3701-3706,3714.
[14]孔若岚,院金烨,王淑贤,等.龙骨-牡蛎药对源流考证及配伍探析[J].中医药学报,2026,54(4):61-66.
[15]邢梓,侯俊玲,赵一帆,等.基于超分子体系探究矿物药龙骨在含柴胡的角药配伍中的作用机制[J].中国实验方剂学杂志,2024,30(14):191-198.
[16]MEDINA I,FILIPPOVA N,BAKHRAMOV A,et al.Calcium-induced inactivation of NMDA receptor-channels evolves independently of run-down in cultured rat brain neurones[J].Physiol,1996,495(1):411-427.
[17]王冬,刘颖,李廷利.龙骨对自由活动大鼠睡眠时相的影响[J].时珍国医国药,2008,20(9):2129-2130.
[18]蔡泳源,严诏琦,王秋铭,等.老年冠心病伴焦虑抑郁的病机与治法探撷[J].北京中医药大学学报,2026,49(3):311-318.
[19]王倩,曾培,袁莉莉,等.柴胡加龙骨牡蛎汤调控NF-κB信号通路对癫痫大鼠神经炎症及海马神经元损伤的影响[J].陕西中医,2021,42(10):1327-1332,1362.
[20]赵建军,彭晓明,李婷婷,等.基于TLR4/MyD88/NF-κB信号通路探讨龙牡安神颗粒对慢性束缚应激小鼠焦虑行为的影响[J].中成药,2022,44(11):3476-3482.
[21]何起臣,金立强,贾运涛,等.黄芩素通过TLR4/MуD88/NF-κB信号通路减轻抑郁症小鼠神经炎症的作用机制研究[J].天然产物研究与开发,2026,38(1):46-53.
[22]徐则,魏凤琴,郭紫霞,等.基于“肝胆同治”治疗抑郁症研究概述[J].辽宁中医药大学学报,2026,28(4):140-145.
[23]GE F,YANG H,LU W T,et al.Ovariectomy induces microglial cell activation and inflammatory response in rat prefrontal cortices to accelerate the ahronic unpredictable stress-mediated anxiety and depression[J].Biomed Res Int,2020:360975.
[24]LI J,WANG H L,DU C B,et al.HUC-MSCs ameliorated CUMS-induced depression by modulating complement C3 signaling-mediated microglial polarization during astrocyte-microglia crosstalk[J].Brain Res Bull,2020,163:109-119.
[25]TILLMON H,SOTEROS M B,SHEN L,et al.Complement and microglia activation mediate stress-induced synapse loss in layer 2/3 of the medial prefrontal cortex in male mice[J].Nature Communications,2024,15(1):9803.
[26]RAWLS A,NYUGEN D,DZIABIS J,et al.Microglial MyD88-dependent pathways are regulated in a sex specific manner in the context of HMGB1-induced anxiety[J].Bio Rxiv,2024:590482.
[27]YUKA I,TOMOYUKI F.The impact of stress on immune systems and its relevance to mental illness[J].Neuroscience Research,2021,17516-17524.
[28]徐兆琴,孙永康,屈楠,等.基于“心藏神”理论探讨卒中后失眠病机与治法[J].吉林中医药,2026,46(3):265-269.
[29]林艳华.《本草纲目·百病主治药》不眠药物的文献研究[D].济南:山东中医药大学,2021.
[30]刘黎明,彭帅军,苏攀,等.远志抗抑郁作用机制研究进展[J].中国实验方剂学杂志,2025,31(5):300-309.
[31]刘星雨,周峰,王艺涵,等.经典名方中合欢类药材的本草考证[J].中国中医基础医学杂志,2026,32(4):906-920.
[32]殷璐瑶,麻京豫,宋朝功.酸枣仁汤的药理作用及临床应用研究进展[J].中草药,2025,56(19):7237-7246.
[33]唐雪燕,秦令祥,曹源,等.酸枣仁总皂苷提取工艺优化及其改善睡眠作用机制研究[J].食品安全质量检测学报,2023,14(17):147-155.
[34]陈俣祯,赵永智,张亦文,等.远志提取物通过调节NLRP3炎症小体和NF-κB通路缓解慢性不可预测轻度应激诱导的大鼠抑郁行为[J].数字中医药(英文版),2024,7(2):184-194.
[35]HU Y,LIU M,LIU P,et al.Possible mechanism of the antidepressant effect of 3,6’-disinapoyl sucrose from Polygala tenuifolia willd[J].Journal of Pharmacy and Pharmacology,2011,63(6):869-874.
[36]梁雨璐,张洁,李忆红,等.整合网络毒理学和网络药理学的合欢皮抗焦虑毒效机制探究[J].药物评价研究,2021,44(7):1411-1424.
[37]熊永豪,冯波,牛源菲,等.合欢皮对小鼠焦虑行为影响及抗焦虑活性部位筛选[J].世界中医药,2018,13(4):790-793,798.
[38]ZHONG F R,SHEN Y C,HAO X K,et al.Flavonoids from polygoni multiflori caulis alleviates p-chlorophenylalanine-induced sleep disorders in mice[J].Industrial Crops & Products,2024:218119002.
[39]高莉,徐笑,马梦娜.调神阴阳平衡针刺配合解郁丸治疗伴焦虑抑郁状态慢性失眠临床研究[J].实用中医药杂志,2025,41(11):2120-2123.
[40]张苏祥,马金丹,吕颖楠,等.基于“督脉不通-脑神失养”探讨通督治疗对脑卒中后抑郁HPA轴亢进的调节作用[J].长春中医药大学学报,2026,42(5):524-527.
[41]胡亦明,杨蕤,韦春昕,等.基于HPA轴-MEK/ERK信号通路探讨柴胡加龙骨牡蛎汤治疗广泛性焦虑症大鼠的作用机制[J].中国中医药信息杂志,2025,32(6):105-111.
[42]王晓滨,许瑞,孔明月,等.柴胡加龙骨牡蛎汤对慢性应激抑郁大鼠强迫游泳行为及HPA轴的影响[J].哈尔滨医科大学学报,2014,48(3):198-201.
[43]彭小玲,龙华君,柏正平.龙华君基于脏腑别通理论的“心-胆”轴论治不寐经验[J].中医药临床杂志,2026,38(4):731-734.
[44]许静,惠振亮,张晓乐,等.探讨“脑-肠轴”理论下中医药治疗卒中后抑郁研究进展[J].陕西中医,2026,47(1):133-136.
[45]段丽敏,袁媛,赵强,等.基于“郁病相生理论”探析慢性胃炎伴焦虑抑郁状态病机与治则[J].陕西中医,2025,46(6):800-804.
[46]付晓星,向越.柴胡龙牡方配合穴位贴敷在冠心病PCI后焦虑患者中的应用效果[J].临床医学研究与实践,2023,8(16):118-121.
[47]王威,范倩,王帅,等.柴胡龙牡方联合穴位贴敷治疗冠心病冠脉介入治疗术后焦虑患者的临床观察[J].广州中医药大学学报,2021,38(4):675-681.
[48]王梦玺,吴晨洁,曹培华,等.柴胡加龙骨牡蛎汤治疗冠心病合并焦虑抑郁状态疗效和安全性的系统评价与Meta分析[J].中国医院药学杂志,2020,40(24):2553-2560.
[49]彭晓明,唐珂.龙牡安神胶囊对原发性高血压患者焦虑障碍的疗效观察[J].甘肃医药,2021,40(7):595-596,610.
[50]王菲,蔡峥.柴胡加龙骨牡蛎汤加减治疗老年原发性高血压疗效及对患者内皮损伤标志物水平和血压水平影响[J].陕西中医,2019,40(9):1261-1264.

相似文献/References:

[1]索晓菲,王亚红△,王居新,等.软坚通脉汤治疗冠心病PCI术后Ⅱ期心脏康复疗效〖JZ〗及对患者生活质量的影响*[J].陕西中医,2020,(1):29.

备注/Memo

备注/Memo:
甘肃省中医药管理局科技项目(GZKG-2024-59);甘肃省自然科学基金资助项目(24JRRA1039)
更新日期/Last Update: 2026-08-13